4//SEC Filing
Perkins Adelene Q 4
Accession 0000899243-18-006636
CIK 0001113148other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:22 PM ET
Size
5.7 KB
Accession
0000899243-18-006636
Insider Transaction Report
Form 4
Perkins Adelene Q
Pres & Chief Business Officer
Transactions
- Sale
Common Stock
2018-03-05$2.78/sh−5,000$13,890→ 607,252 total
Holdings
- 12,391.26(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]The disposition reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2017.
Documents
Issuer
INFINITY PHARMACEUTICALS, INC.
CIK 0001113148
Entity typeother
Related Parties
1- filerCIK 0001375124
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:22 PM ET
- Size
- 5.7 KB